ABSTRACT In genetic association studies a conventional test statistic is proportional to the correlation coefficient between the trait and the variant, with the result that it lacks power to detect association for low-frequency variants. Considering the link between the conventional association test statistics and the linkage disequilibrium measure r 2 , we propose a test statistic analogous to the standardized linkage disequilibrium D9 to increase the power of detecting association for low-frequency variants. By both simulation and real data analysis we show that the proposed D9 test is more powerful than the conventional methods for detecting association for low-frequency variants in a genome-wide setting. The optimal coding strategy for the D9 test and its asymptotic properties are also investigated. In summary, we advocate using the D9 test in a dominant model as a complementary approach to enhancing the power of detecting association for low-frequency variants with moderate to large effect sizes in case-control genome-wide association studies.
I
N testing for association between a trait and a genetic variant, conventional methods fit to data generalized linear models, e.g., logistic regression models for a binary trait and linear regression models for a continuous trait (Balding 2006) . Under the assumption of an additive genetic model, the power of the test is proportional to the locus-specific narrow sense heritability-the proportion of the trait variance explained by the additive genetic effect of the variant (Chapman et al. 2003) -which is essentially the square of the linear correlation coefficient r 2 between the trait and the variant. In this article we call tests based on the correlation coefficient r 2 -type tests. The power of an r 2 -type test can be shown to be proportional to effect size 2 3 pð1 2 pÞ, where p denotes the allele frequency (Chapman et al. 2003; Spencer et al. 2009 ). The power of an r 2 -type test decreases as the minor allele frequency (MAF) of the variant decreases, which is one of the reasons genome-wide association studies (GWAS) mostly identify associations with common variants. Association of alleles at different loci on the same chromosome is referred to as gametic phase disequilibrium, or linkage disequilibrium (LD). Various measures of LD are proposed in the literature (Hedrick 1987; Devlin and Risch 1995; Mueller 2004) , among which two are commonly used, the correlation coefficient r 2 (Hill and Robertson 1968) and the standardized gametic disequilibrium coefficient D9 (Lewontin 1964) . Numerous studies compare the two measures from the perspectives of inferring population evolutionary history and mapping genes (for a review, see e.g., Slatkin 2008) . A consensus concerning the two measures is that D9 is more robust to allele frequency. Although neither measure is independent of the allele frequency (Edwards 1963; Lewontin 1988) , the range of D9 is always between 2 1:0 and þ1:0, regardless of allele frequency, whereas the limits of r 2 depend on the allele frequencies at both loci. D9 more accurately reflects the recombination patterns (Hedrick 1988) , in particular in the case of low allele frequencies, which can facilitate pinpointing diseasecausing mutations (Devlin and Risch 1995; Guo 1997) . Note that in the case of small sample sizes and low allele frequencies, the absolute magnitude of D9 tends to be overestimated (Zapata et al. 2001; Teare et al. 2002; Pe'er et al. 2006) .
Inspired by these characteristics of D9, we propose an alternative approach to gene mapping using statistics based on D9 instead of the conventional r 2 -type tests. We hypothesized that a D9-type test would be more powerful than r 2 -type tests in detecting association for low-frequency variants.
Method
Consider two diallelic loci A and B, with alleles A 1 and A 2 at locus A and alleles B 1 and B 2 at locus B, i.e., the factors A and B in Table 1 stand for loci A and B, respectively. Denote by p k• and p •k , where k 2 f1; 2g, allele (relative) frequencies, and by p ij , where i; j 2 f1; 2g, haplotype (relative) frequencies. The gametic disequilibrium coefficient is defined as
(1) (Lewontin and Kojima 1960) . The measure
is the square of Pearson's correlation coefficient that measures the linear dependence between the two loci (Hill and Robertson 1968) . The measure
where
; is a standardized D obtained on dividing it by its theoretical maximum given the allele frequencies (Lewontin 1964) . Let factor B in Table 1 stand for the affection status of a disease, with B 1 denoting cases and B 2 denoting controls, and consider association between the disease and the alleles, assumed to be independent, of a diallelic locus A. The widely used Pearson's x 2 test statistic is defined as 12 D9
where 
that at some points the parameters lie on the boundary of the parameter space (Mangin et al. 2008) . When D ¼ 0 the asymptotic variance of D9 cannot be obtained by the delta method because D max is not continuous at this point; however, from a practical point of viewD9 ¼ 0 has a point mass with zero probability. For the sake of completeness, we define x 2 D9 ¼ 0 atD9 ¼ 0 with a probability of zero. When one cell equals 0, or when both diagonal/antidiagonal cells = 0, D 9 ¼ 1 and VarðD9Þ ¼ 0, and the test statistic x 2 D9 is undefined. One way to circumvent this is to add 0.5 to each cell. Considering the known upward bias ofD9 in the case of small sample sizes and low allele frequencies, we take a more conservative approach by adding 0.5 to the cell in the table with the smallest number while keeping the marginal totals fixed; when there are two such cells belonging to the same row or column, no penalty will be taken.
First we provide a numerical example illustrating differences between the D9-type measures and the r 2 -type measures for association of low-frequency exposures in a case-control study under both null and alternative hypotheses. Consider a balanced design with 200 cases and 200 controls and a risk factor with an exposure rate of 0.05, i.e., n •1 ¼ n •2 ¼ 200 and n 11 ¼ 10 in Table 1 . We calculatedD9 andr 2 , and their corresponding test statistics x 2 D9 and x 2 r 2 , with n 11 ¼ 10 fixed and n 12 decreasing from 10 to 0 (Table 2) .
Since both the validity and power of a test depend on the coding schemes it employs in genetic studies (Sasieni 1997; Freidlin et al. 2002) , we investigated what coding scheme to use when applying the D9 test in the case of low-frequency variants. Consider a balanced case-control study with a total of N subjects and a diallelic locus with minor allele A and major allele a. Denote by x i and y i , where i 2 f0; 1; 2g indicates the copy number of allele A, the numbers of individuals with genotypes aa, Aa, and AA in cases and controls, respectively (Table 3 ). For simplicity, assume x 2 ¼ y 2 ¼ 0, i.e., no individual with the AA genotype is observed, since the D9 test is specifically designed for low-frequency variants. As a result, we need only compare two coding schemes-one takes each allele as a unit, which we call the "allelic model"; the other takes each individual as a unit, which we call the "dominant model."
We compared the power of the D9 test with that of Pearson's x 2 test and the likelihood-ratio test (LRT) to detect association of variants with various MAFs in a GWAS setting. To make a fair comparison, we simulated variants of different MAFs with equal chance of being detected by a standard method at a nominal level and compared the empirical power of the different methods in a genome-wide screen context. Specifically, for a given MAF f 0 in controls, the MAF f 1 in cases was computed, using the arcsine transformation, such that the power to detect the MAF difference between the cases and controls was 0.8 at a nominal 0.05 significance level (Cohen 1988) . Three MAF categoriesdefined by the intervals ð0; 0:01Þ, ½0:01; 0:10Þ, and ½0:10; 0:50-were considered. In each category 30 singlenucleotide polymorphisms (SNPs) associated with the disease were simulated by randomly choosing values of f 0 . To mimic a GWAS according to the MAF spectrum of the Affymetrix Genome-wide Human SNP Array 6.0 in Caucasians, we simulated 1 million null SNPs, among which 15, 20 and 65% were with MAFs randomly chosen from ð0; 0:01Þ, ½0:01; 0:10Þ, and ½0:10; 0:50, respectively. Again we considered a balanced design with an equal number (200, 500, 1000, or 2000) of cases and controls. In each setting, 100 replicates were generated. For each replicate, we recorded the statistics and performed the power analysis in two ways. One was to count the number of true positive SNPs among the top m 2 f30; 40; ⋯; 90; 100g SNPs. The other way, adjusting for multiple testing, was to fit to the statistics an empirical null distribution, estimate the local false discovery The structure of data are as in Table 1 , with n •1 ¼ n •2 ¼ 200, n 11 ¼ 10, and n 12 equal to the number indicated in the first column; 0.5 was added to the cell in the table with the smallest number, as described in Methods, before calculating the entries of this table. Table 3 Data distributions under different coding schemes for a low-frequency variant in a balanced case-control study
N=2 N A and a denote the minor and major alleles, respectively. For simplicity, we assume that no individual with the AA genotype is observed.
rate (FDR) (Efron 2004; Efron 2007a,b) , and then count the number of true positive SNPs meeting a certain FDR criterion.
As a proof-of-principle example, we applied the D9 test and the LRT in a GWAS of plasma levels of triglycerides with nonsynonymous SNPs in the African Americans (AAs) of the Dallas Heart Study (DHS) (Victor et al. 2004 ). There were 1722 individuals with complete phenotypes-triglycerides, body mass index (BMI), age, sex-after deleting those taking cholesterol-lowering medicine. We first fitted to data the linear regression model
where the ancestry of each individual was inferred using ancestry-informative markers (Xing et al. 2011) , to obtain the residuals e. We then sampled the lowermost and uppermost quintiles of the residuals (n = 345) as cases and controls, respectively. There was a total of 8968 nonsynonymous SNPs assayed across the autosomes. We first filtered out singletons and those out of Hardy-Weinberg equilibrium (HWE; P-value , 1:0 3 10 25 ) in the whole AA population, and then filtered out monomorphic ones in the case-control sample, resulting in 8268 SNPs for further analysis. We performed genome-wide scans using both the D9 test and the LRT. Fisher's exact test and Pearson's x 2 test were omitted because the LRT is more powerful in detecting association for low-frequency variants (Xing et al. , 2013 , which was confirmed in the simulation study of this article.
Finally, we explored by simulation the asymptotic properties of the D9 test, in particular whether the type I error rate is well calibrated for the D9 test under the null hypothesis at different sample sizes. We considered a balanced design with equal numbers (200, 500, 1000, or 2000) of cases and controls. Variants with low frequencies were of particular interest and we simulated SNPs with MAFs equal to 0.005, 0.01, 0.05, and 0.1. In each setting 100,000 replicates, in each of which all the SNPs were polymorphic, were generated. Each data set could be summarized into a 2 3 2 table and we tested the allele frequency difference between cases and controls. The test statistic x 2 D9 was recorded to estimate its empirical distribution. We also performed Fisher's exact test, Pearson's x 2 test, and the LRT, for comparison. Except in the case of Fisher's exact test, we calculated P-values assuming an asymptotic distribution of x 2 1 . The empirical type I error rates at a nominal a significance level were calculated as the proportion of the 100,000 replicates for which the P-value was # a.
Results
Compared with the r 2 -type test statistic, the D9-type test statistic under the alternative hypothesis is more distinct from that under the null hypothesis ( Table 2) . Under the null hypothesis of no association-n 11 = n 12 = 10-bothD9 andr 2 equal zero. As n 12 decreases,D9 approaches one whereasr 2 remains minimal, which is expected because the range ofr 2 is constrained by frequencies of both factors based on their definitions. In contrast, by definition x 2 D9 and x 2 r 2 should have the same range regardless of frequencies. Under the null hypothesis, both equal zero; however, as n 12 decreases to 1 and 0, which correspond to situations of strong association, x 2 D9 increases more rapidly than x 2 r 2 . This suggested the potential advantage of using the D9-type tests to detect association for low-frequency exposures, as further illustrated in a GWAS below.
Denote byD9 a andD9 d the sample estimates of D9, and by x 2 a and x 2 d the D9-type test statistics under the allelic and dominant models, respectively. It can be shown thatD9 d ¼D9 a and x 2 d . x 2 a in the case of a balanced case-control study for a lowfrequency variant (see Appendix for details). Thus analyzing data under a dominant model leads to greater power than analyzing data under an allelic model for a low-frequency variant using the D9-type test, and therefore we employ the dominant coding scheme in what follows. It is of interest to note that by using the dominant model we also circumvent the potential issue of deviation from HWE of variants, which is a known issue impairing the validity of tests based on the allelic model coding scheme (Sasieni 1997) .
In a genome-wide screen the D9 test is superior to the LRT and Pearson's x 2 test in detecting low-frequency variants, in particular when the sample size is small (Figure 1 and Figure 2) ; its gain in power diminishes as the sample size increases. Given the sample size, the D9 test is most powerful in detecting association for low-frequency variants; its power decreases as the MAF increases. In contrast, the power of the other two tests increases as the MAF increases. The power of the three tests converges with increasing MAF and sample size. It is interesting to note that for common variants, when using ranking for the cutoff, the D9 test selects fewer true positive variants than the other two methods ( Figure 1) ; however, when using the FDR as the criterion to correct for multiple testing, the D9 test selects more true positive variants, especially when the sample size is small (Figure 2) . The underlying reason is that the null distribution and the alternative distribution of the D9 test statistics are more distinguishable than those of the LRT statistics and Pearson's x 2 test statistics (Table 4 ). In Table 5 we list the union of the top 10 SNPs in the genome-wide scan of plasma triglyceride levels in the casecontrol study of DHS AAs using the D9 test and the LRT. There was a total of 13 SNPs, among which 7 SNPs were ranked in the top 10 by both methods. All the top 10 SNPs by the LRT were ranked in the top 15 by the D9 test; however, common variants tended to be ranked higher by the LRT than by the D9 test. In contrast, there were two low-frequency variants (MAFs , 0.005) ranked in the top 10 by the D9 test but ranked much lower by the LRT. There was one SNP with local FDR less than 0.05 using the D9 test, but none using the LRT.
The D9 test statistic converges to a distribution of x 2 1 as both the MAF and the sample size increase; however, when the MAF is low and the sample size is small, the distribution has a heavy tail (supporting information, Figure S1 ). Its type I error rate is well preserved at the nominal 0.05 significance level but inflated at more stringent test levels (Table 6 ). We previously compared Fisher's exact test, Pearson's x 2 test, and the LRT, concluding that Fisher's exact test is the most conservative, whereas the LRT is the most liberal . Compared to the LRT, the D9 test is more conservative at a loose criterion (a = 0.05), but more liberal at a stringent criterion (a , 0.001), especially in the case of testing for the association of low-frequency variants. This property suggests proper usage of the D9 test: on one hand, the D9 test is not a valid test at low test levels; on the other hand, the D9 test statistic has the advantage of detecting association signals of low-frequency variants over that of common variants in a genome-wide screen setting, as we have demonstrated by both simulated and real data of genome-wide screens.
Discussion
Conventional wisdom regarding the LD measures D9 and r 2 is that D9 is more useful in population genetics, such as for inferring recombination events, whereas r 2 is more useful in association mapping (Mueller 2004) , because the power of a test between the causal variant and the proxy variant being examined is proportional to r 2 (Pritchard and Przeworski 2001; Chapman et al. 2003; Spencer et al. 2009; Lin et al. 2012) . However, the r 2 -type association test lacks power for low-frequency variants. Instead, in this article we propose a D9-type test. Based on D9's biological property of measuring recombination events, and by making use of its low sensitivity to allele frequencies and its upward bias estimate in the case of small sample sizes and low allele frequencies, we aimed to enhance the power of detecting association for low-frequency variants in genome-wide screens. In the D9-type test, the inflation ofD9 under the null is largely controlled by the large accompanying variance (Zapata et al. 1997; Teare et al. 2002) and by adding 0.5 to the minimum cell while keeping the marginal totals fixed. The D9 test is conservative at a loose criterion (a = 0.05), but liberal at a stringent criterion (a , 0.001), in particular when testing for association with low-frequency variants, which favors low-frequency variants with modest to large effect sizes in a genome-wide screen. As the sample size Figure 1 Power comparison of different methods using the ranking criterion. The x-axis is the number of top single-nucleotide polymorphisms (SNPs) in rank and the y-axis is the fraction of those SNPs associated with the disease given the ranking criterion. The plots are based on the mean of 100 replicates. Each row corresponds to a different sample size of N cases and controls, and each column corresponds to a minor allele frequency (MAF) category of SNPs. and the MAF increase, the test statistic converges to a x 2 1 distribution under the null hypothesis. After standardization,D9 andr 2 are comparable in terms of precision, accuracy, and efficiency, but the former has an advantage in the fact that its range of variation is always the same regardless of MAFs (Zapata 2011) , which, we speculate, explains its superior power for low-frequency variants in genome-wide screens.
In the literature, a metric closely related to D9 is the socalled "optimal measure of allelic association" r, which equals jD9j. It was proposed in a genetic mapping method based on the Malécot model for isolation by distance (Collins and Morton 1998; Morton et al. 2001; Morton et al. 2007 ). The Malécot model uses a composite likelihood to combine association information from multiple variants; however, at each site the association information is still summarized by Pearson's x 2 statistic, which is fundamentally different from the D9-type test we propose. The metric r originated from population genetic theories with an intuitive appeal-it is an estimate of the probability that a random haplotype has descended without recombination from a founder population (Morton et al. 2001; Shete 2003) . This feature sheds light on the D9-type test in detecting association for low-frequency variants; a highly penetrant, lowfrequency, causal variant is expected to be in complete LD/association, i.e., D9 = 1, with disease affection status. Another metric closely related to D9 is the robust attributable risk d (Bengtsson and Thomson 1981; Devlin and Risch 1995) . In the case of rare diseases and random sampling, such that the disease frequency is smaller than the MAF of a variant, these two metrics are approximately equal (Devlin and Risch 1995) . In a case-control study design, the two metrics have the same numerator, which is D , but different denominators-p •1 p 22 and p 1• p •2 for d and D9, respectively. In a case-control design, p •1 p •2 , but for a low-frequency variant p 1• , p 22 so that D9 . d. Therefore, D9 should be a more sensitive metric for detecting association of lowfrequency variants. Both r and d were applied in a composite likelihood approach to locating a disease causal gene/variant assuming an evolutionary model (Terwilliger 1995; Devlin et al. 1996; Collins and Morton 1998; Morton et al. 2001 Morton et al. , 2007 . On one hand, we suspect that imposing a population Figure 2 Power comparison of different methods using the false discovery rate (FDR) criterion. The x-axis is the local FDR and the y-axis is the number of SNPs associated with the disease given the FDR criterion. The plots are based on the mean of 100 replicates. Each row corresponds to a different sample size of N cases and controls, and each column corresponds to a MAF category of SNPs.
genetic model may harm its power in gene mapping for complex diseases with locus and allelic heterogeneity; on the other hand, we speculate that using the information directly from r/D9, as the D9-type test, instead of from Pearson's x 2 statistic at each site to form the composite likelihood, will increase its power, especially in isolated populations with relatively homogenous disease etiology.
The D9 test is highly sensitive to association signals of low-frequency variants and so it can capture association missed by the r 2 -type test; however, to avoid spurious results, it is important to replicate findings in independent samples; to estimate significance accurately, a permutation procedure is needed. In the case of low-frequency variants, we proved that the D9 test is more powerful in a dominant coding scheme than in an allelic coding scheme; however, this does not hold over the full allele frequency spectrum. Thus we advocate using the D9 test in a dominant model as a complementary approach to the r 2 -type test instead of a replacement for it in GWAS. By doing so we also circumvent the potential issues brought up when a variant is out of HWE. Since the advantage of the D9 test lies in lowfrequency variants, it is not a primary interest of this article to construct a D9-type genotypic test for a 2 3 3 table, although this is under investigation. In this article we present a single-variant D9 test to enhance the power of detecting association for low-frequency variants with moderate to large effect sizes. Previously, we compared the power of the single-variant LRT and two multivariant analysis approaches-the burden test and variance component method-for analyzing sequence data and showed that as long as there is a variant with a moderate to large effect size and stable expressivity, the single-variant LRT has the potential to identify it . Given that the D9 test is more powerful than the LRT for low-frequency variants, this conclusion will also hold for the D9 test. A further potential research topic would be to extend the D9 test to be multivariant, which, we expect, will enhance the power of detecting loci of multiple low-frequency variants with small effect sizes.
Variants attaining genome-wide significance explain only a small fraction of the genetic variance of complex traits (Manolio et al. 2009) , and it was shown that a large proportion of the heritability is not so much missing as hidden because the individual effects are too small to pass stringent significance tests (Yang et al. 2010) ; this is relevant to not only GWAS, but also sequencing studies. Apart from increasing the sample size, more efficient study designs and more powerful methods are needed to extract from random noise true associations, in particular, low-frequency variants with moderate to large effect sizes. For example, employing a weighted FDR control procedure we previously identified, with a sample size of 7400, low-frequency variants at FOXA2 associated with plasma glucose levels (Xing et al. 2010) , which was missed by the regular method with sample sizes of 6000 (Banasik et al. 2012) and 46,000 (Dupuis et al. 2010) , but was confirmed later with an even larger sample size of .100,000 and by accounting for interaction with BMI in a sample of .50,000 (Manning et al. 2012) . In this study we proposed a test based on the standardized LD measure D9 that is powerful in detecting association for low-frequency variants in genome-wide screens. We recommend using the D9 test as a complementary approach to the conventional r 2 -type test to detect association for variants over the full allele frequency spectrum. 
